help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 19, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1016
A more recent version of this article appeared on October 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/10/5884    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Straub, R. H.
Right arrow Articles by Lorenz, H.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Straub, R. H.
Right arrow Articles by Lorenz, H.-M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*17ALPHA-HYDROXYPROGESTERONE
*ESTRADIOL
*ESTRONE
*HYDROCORTISONE
Medline Plus Health Information
*Steroids

Submitted on May 6, 2005
Accepted on July 11, 2005

Adrenal and gonadal hormone variations during a febrile attack in a woman with tumor necrosis factor (TNF) - receptor-associated periodic syndrome (TRAPS)

Rainer H. Straub*, Peter Härle, Martin Kriegel, Jürgen Schölmerich, and Hanns-Martin Lorenz

Laboratory of Neuroendocrinoimmunology, Department of Internal Medicine I, Division of Rheumatology, University Hospital, 93042 Regensburg, Germany; Department of Medicine V, Division of Rheumatology, University of Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany; Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, U.S.A.

* To whom correspondence should be addressed. E-mail: rainer.straub{at}klinik.uni-regensburg.de.

Context: Tumor necrosis factor (TNF)-receptor-associated periodic syndrome (TRAPS) is a hereditary fever syndrome which results from mutations in the TNF-receptor superfamily 1A gene (TNFRSF1A). It is characterized by periodic fever, arthralgia, abdominal pain, myalgia, headache, and skin lesions.

Objective: Since adrenal and gonadal hormone cascades are modulated by TNF, this study aimed to investigate specific hormones and enzyme steps during an attack phase in a women with TRAPS.

Design: Morning blood samples were taken from a 38 yr-old women before, during, and after the febrile episode in the late luteal, menstrual, and early follicular phase of the menstrual cycle, respectively.

Results: Serum cortisol levels were markedly increased throughout the entire observation period and demonstrated a dip during the attack phase. In contrast, serum levels of dehydroepiandrosterone (DHEA) and 17-hydroxyprogesterone demonstrated a sharp rise during the febrile episode. DHEA in relation to androstenedione or cortisol was increased. Indicative of aromatase activation, estrone and 17{beta}-estradiol demonstrated a marked increase during the attack phase.

Conclusion: This study suggests that some important steroid hormone conversion steps are activated (aromatase) and inhibited (second step of the P450c17 and the 3{beta}-hydroxysteroid dehydrogenase) during the inflammatory attack phase in a TRAPS patient. These changes of enzyme pathways are typical on the basis of increased TNF signaling.


Key words: TNF-receptor-associated periodic syndrome • TRAPS • dehydroepiandrosterone • 17-hydroxyprogesterone • androstenedione • cortisol • aromatase • estrone • 17{beta}-estradiol







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society